These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 1942539)

  • 1. Characterization of the 5q- breakpoint in an acute nonlymphocytic leukemia patient using pulsed-field gel electrophoresis.
    Thornton DE; Theil K; Payson R; Balcerzak SP; Chiu IM
    Am J Med Genet; 1991 Dec; 41(4):557-65. PubMed ID: 1723247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-kit ligand augments granulocyte-macrophage colony growth from patients with 5q- syndrome.
    Rosenfeld CS; Nemunaitis J; Sherer CR; Zeigler ZR; Shadduck RK
    Stem Cells; 1993 Nov; 11(6):562-7. PubMed ID: 7509225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelodysplastic disorders with hemizygous M-CSF receptor gene loss do not show point mutations of codon 969 within the remaining allele.
    Jaquet K; Kreipe H; Felgner J; Boultwood J; Parwaresch MR
    Leukemia; 1993 Apr; 7(4):650-2. PubMed ID: 8464244
    [No Abstract]   [Full Text] [Related]  

  • 4. [Parallel loss of c-FMS and GM-CSF genes in myeloid leukemias with 5q-chromosome].
    Tanaka K; Takechi M; Shigeta C; Oguma N; Kamada N; Takimoto Y; Kuramoto A; Kyo T; Dohy H
    Rinsho Ketsueki; 1991 Sep; 32(9):931-7. PubMed ID: 1942539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletions of chromosome 5 in malignant myeloid disorders.
    Le Beau MM
    Cancer Surv; 1992; 15():143-59. PubMed ID: 1451109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic lesions in preleukemia.
    Carter G; Ridge S; Padua RA
    Crit Rev Oncog; 1992; 3(4):339-64. PubMed ID: 1420444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5q- myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics.
    Eisenmann KM; Dykema KJ; Matheson SF; Kent NF; DeWard AD; West RA; Tibes R; Furge KA; Alberts AS
    Oncogene; 2009 Oct; 28(39):3429-41. PubMed ID: 19597464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current treatment options for myelodysplastic syndromes].
    Nolte F; Hofmann WK
    Dtsch Med Wochenschr; 2010 Sep; 135(38):1863-9. PubMed ID: 20842606
    [No Abstract]   [Full Text] [Related]  

  • 9. The process of leukemogenesis.
    Irons RD; Stillman WS
    Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1239-46. PubMed ID: 9118899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid malignancies and chromosome 5 deletions.
    Westbrook CA; Keinänen MJ
    Baillieres Clin Haematol; 1992 Oct; 5(4):931-42. PubMed ID: 1339191
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.